nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—UGT1A1—lung cancer	0.00284	0.269	CrCbGaD
Baclofen—Ibuprofen—CXCL8—lung cancer	0.00268	0.254	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—lung cancer	0.00175	0.166	CrCbGaD
Baclofen—Chlorpropamide—ABCB1—lung cancer	0.00113	0.107	CrCbGaD
Baclofen—Ibuprofen—PTGS2—lung cancer	0.000782	0.0741	CrCbGaD
Baclofen—Ibuprofen—ALB—lung cancer	0.000697	0.0661	CrCbGaD
Baclofen—Ibuprofen—ABCB1—lung cancer	0.000665	0.063	CrCbGaD
Baclofen—GABBR2—GPCR downstream signaling—ANXA1—lung cancer	0.000615	0.00186	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000605	0.00183	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SDC4—lung cancer	0.000598	0.00181	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTHLH—lung cancer	0.000594	0.0018	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GRM8—lung cancer	0.000594	0.0018	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DUSP3—lung cancer	0.000586	0.00177	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000584	0.00176	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—APP—lung cancer	0.000583	0.00176	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RHEB—lung cancer	0.000574	0.00174	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—POMC—lung cancer	0.000567	0.00171	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ANXA1—lung cancer	0.000558	0.00169	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRM8—lung cancer	0.000544	0.00165	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AXL—lung cancer	0.000544	0.00165	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—OXTR—lung cancer	0.000538	0.00163	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GRP—lung cancer	0.000538	0.00163	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—MDM2—lung cancer	0.000534	0.00161	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—POMC—lung cancer	0.000533	0.00161	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000532	0.00161	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—APP—lung cancer	0.000529	0.0016	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SKI—lung cancer	0.000527	0.00159	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—AVP—lung cancer	0.000517	0.00156	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GNG11—lung cancer	0.000504	0.00152	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GRP—lung cancer	0.000489	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—OXTR—lung cancer	0.000489	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—BRAF—lung cancer	0.000488	0.00148	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PXN—lung cancer	0.000458	0.00138	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GNG11—lung cancer	0.000458	0.00138	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000455	0.00137	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AVP—lung cancer	0.000453	0.00137	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADCY1—lung cancer	0.000453	0.00137	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRP—lung cancer	0.000448	0.00136	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKR1C1—lung cancer	0.000448	0.00136	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—OXTR—lung cancer	0.000448	0.00136	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—lung cancer	0.000439	0.00133	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—COL4A2—lung cancer	0.000423	0.00128	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PTHLH—lung cancer	0.000421	0.00127	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GNG11—lung cancer	0.00042	0.00127	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GIPR—lung cancer	0.000413	0.00125	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—lung cancer	0.000412	0.00125	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AVP—lung cancer	0.000412	0.00124	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADCY1—lung cancer	0.000412	0.00124	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MDM2—lung cancer	0.000409	0.00124	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—RAF1—lung cancer	0.000408	0.00123	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PPP2R1B—lung cancer	0.000401	0.00121	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFC—lung cancer	0.0004	0.00121	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ANXA1—lung cancer	0.000396	0.0012	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.00039	0.00118	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SDC4—lung cancer	0.000385	0.00116	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTHLH—lung cancer	0.000383	0.00116	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DUSP3—lung cancer	0.000377	0.00114	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADCY1—lung cancer	0.000377	0.00114	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—APP—lung cancer	0.000376	0.00114	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RHEB—lung cancer	0.00037	0.00112	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PPP2R1B—lung cancer	0.000368	0.00111	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SMARCA4—lung cancer	0.000368	0.00111	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—AVP—lung cancer	0.000361	0.00109	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ANXA1—lung cancer	0.00036	0.00109	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HSPB1—lung cancer	0.000355	0.00107	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTHLH—lung cancer	0.000351	0.00106	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM8—lung cancer	0.000351	0.00106	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.00035	0.00106	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—HRAS—lung cancer	0.000348	0.00105	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—POMC—lung cancer	0.000343	0.00104	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—APP—lung cancer	0.000341	0.00103	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SKI—lung cancer	0.00034	0.00103	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ANXA1—lung cancer	0.00033	0.000997	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FLT1—lung cancer	0.000319	0.000966	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000317	0.000958	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—lung cancer	0.000316	0.000957	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APP—lung cancer	0.000313	0.000945	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH3—lung cancer	0.000313	0.000945	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF9—lung cancer	0.00031	0.000937	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—POMC—lung cancer	0.000301	0.000911	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUNB—lung cancer	0.000296	0.000895	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PXN—lung cancer	0.000295	0.000892	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—HRAS—lung cancer	0.000293	0.000886	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AVP—lung cancer	0.000292	0.000883	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRP—lung cancer	0.000289	0.000873	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—OXTR—lung cancer	0.000289	0.000873	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKR1C1—lung cancer	0.000289	0.000873	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—lung cancer	0.000287	0.000869	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000285	0.000862	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000285	0.000862	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00028	0.000425	CcSEcCtD
Baclofen—Dyspnoea—Etoposide—lung cancer	0.000279	0.000424	CcSEcCtD
Baclofen—Somnolence—Etoposide—lung cancer	0.000279	0.000423	CcSEcCtD
Baclofen—Hepatobiliary disease—Methotrexate—lung cancer	0.000278	0.000423	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000278	0.000841	CbGpPWpGaD
Baclofen—Insomnia—Paclitaxel—lung cancer	0.000278	0.000422	CcSEcCtD
Baclofen—Convulsion—Docetaxel—lung cancer	0.000277	0.00042	CcSEcCtD
Baclofen—Paraesthesia—Paclitaxel—lung cancer	0.000276	0.000419	CcSEcCtD
Baclofen—Hypertension—Docetaxel—lung cancer	0.000276	0.000418	CcSEcCtD
Baclofen—Dyspnoea—Paclitaxel—lung cancer	0.000274	0.000416	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—POMC—lung cancer	0.000274	0.000827	CbGpPWpGaD
Baclofen—Somnolence—Paclitaxel—lung cancer	0.000273	0.000415	CcSEcCtD
Baclofen—Decreased appetite—Etoposide—lung cancer	0.000272	0.000414	CcSEcCtD
Baclofen—Myalgia—Docetaxel—lung cancer	0.000272	0.000413	CcSEcCtD
Baclofen—Chest pain—Docetaxel—lung cancer	0.000272	0.000413	CcSEcCtD
Baclofen—Nausea—Vinorelbine—lung cancer	0.000271	0.000412	CcSEcCtD
Baclofen—Gastrointestinal disorder—Etoposide—lung cancer	0.000271	0.000411	CcSEcCtD
Baclofen—Dyspepsia—Paclitaxel—lung cancer	0.000271	0.000411	CcSEcCtD
Baclofen—Body temperature increased—Cisplatin—lung cancer	0.00027	0.000411	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GNG11—lung cancer	0.00027	0.000817	CbGpPWpGaD
Baclofen—Asthenia—Irinotecan—lung cancer	0.00027	0.00041	CcSEcCtD
Baclofen—Fatigue—Etoposide—lung cancer	0.00027	0.00041	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00027	0.00041	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—STK11—lung cancer	0.000269	0.000813	CbGpPWpGaD
Baclofen—Pain—Etoposide—lung cancer	0.000268	0.000407	CcSEcCtD
Baclofen—Constipation—Etoposide—lung cancer	0.000268	0.000407	CcSEcCtD
Baclofen—Dysuria—Doxorubicin—lung cancer	0.000267	0.000406	CcSEcCtD
Baclofen—Decreased appetite—Paclitaxel—lung cancer	0.000267	0.000406	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—IL6R—lung cancer	0.000267	0.000807	CbGpPWpGaD
Baclofen—Dry mouth—Docetaxel—lung cancer	0.000266	0.000403	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—lung cancer	0.000266	0.000803	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000265	0.000403	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AVP—lung cancer	0.000265	0.000802	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	0.000265	0.000801	CbGpPWpGaD
Baclofen—Fatigue—Paclitaxel—lung cancer	0.000265	0.000402	CcSEcCtD
Baclofen—Pollakiuria—Doxorubicin—lung cancer	0.000264	0.000401	CcSEcCtD
Baclofen—Asthenia—Gemcitabine—lung cancer	0.000263	0.0004	CcSEcCtD
Baclofen—Pain—Paclitaxel—lung cancer	0.000263	0.000399	CcSEcCtD
Baclofen—Constipation—Paclitaxel—lung cancer	0.000263	0.000399	CcSEcCtD
Baclofen—Confusional state—Docetaxel—lung cancer	0.000263	0.000399	CcSEcCtD
Baclofen—Urinary tract disorder—Methotrexate—lung cancer	0.000261	0.000396	CcSEcCtD
Baclofen—Oedema—Docetaxel—lung cancer	0.00026	0.000395	CcSEcCtD
Baclofen—Weight increased—Doxorubicin—lung cancer	0.00026	0.000395	CcSEcCtD
Baclofen—Pruritus—Gemcitabine—lung cancer	0.00026	0.000394	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FOXO3—lung cancer	0.000259	0.000784	CbGpPWpGaD
Baclofen—Urethral disorder—Methotrexate—lung cancer	0.000259	0.000393	CcSEcCtD
Baclofen—Infection—Docetaxel—lung cancer	0.000259	0.000393	CcSEcCtD
Baclofen—Weight decreased—Doxorubicin—lung cancer	0.000259	0.000393	CcSEcCtD
Baclofen—Feeling abnormal—Etoposide—lung cancer	0.000258	0.000392	CcSEcCtD
Baclofen—Hyperglycaemia—Doxorubicin—lung cancer	0.000258	0.000392	CcSEcCtD
Baclofen—Diarrhoea—Irinotecan—lung cancer	0.000258	0.000391	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—VEGFC—lung cancer	0.000257	0.000778	CbGpPWpGaD
Baclofen—Pneumonia—Doxorubicin—lung cancer	0.000256	0.000389	CcSEcCtD
Baclofen—Gastrointestinal pain—Etoposide—lung cancer	0.000256	0.000389	CcSEcCtD
Baclofen—Shock—Docetaxel—lung cancer	0.000256	0.000389	CcSEcCtD
Baclofen—Nervous system disorder—Docetaxel—lung cancer	0.000255	0.000388	CcSEcCtD
Baclofen—Drowsiness—Doxorubicin—lung cancer	0.000255	0.000387	CcSEcCtD
Baclofen—Visual impairment—Methotrexate—lung cancer	0.000255	0.000387	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—MAP2K1—lung cancer	0.000254	0.000769	CbGpPWpGaD
Baclofen—Tachycardia—Docetaxel—lung cancer	0.000254	0.000386	CcSEcCtD
Baclofen—Feeling abnormal—Paclitaxel—lung cancer	0.000253	0.000384	CcSEcCtD
Baclofen—Skin disorder—Docetaxel—lung cancer	0.000253	0.000384	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—lung cancer	0.000253	0.000764	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Paclitaxel—lung cancer	0.000251	0.000382	CcSEcCtD
Baclofen—Diarrhoea—Gemcitabine—lung cancer	0.000251	0.000381	CcSEcCtD
Baclofen—Renal failure—Doxorubicin—lung cancer	0.000251	0.00038	CcSEcCtD
Baclofen—Dizziness—Irinotecan—lung cancer	0.000249	0.000378	CcSEcCtD
Baclofen—Urticaria—Etoposide—lung cancer	0.000249	0.000378	CcSEcCtD
Baclofen—Anorexia—Docetaxel—lung cancer	0.000248	0.000377	CcSEcCtD
Baclofen—Body temperature increased—Etoposide—lung cancer	0.000248	0.000376	CcSEcCtD
Baclofen—Abdominal pain—Etoposide—lung cancer	0.000248	0.000376	CcSEcCtD
Baclofen—Eye disorder—Methotrexate—lung cancer	0.000247	0.000375	CcSEcCtD
Baclofen—Tinnitus—Methotrexate—lung cancer	0.000246	0.000374	CcSEcCtD
Baclofen—Asthenia—Cisplatin—lung cancer	0.000245	0.000373	CcSEcCtD
Baclofen—Cardiac disorder—Methotrexate—lung cancer	0.000245	0.000372	CcSEcCtD
Baclofen—Sweating—Doxorubicin—lung cancer	0.000244	0.000371	CcSEcCtD
Baclofen—Urticaria—Paclitaxel—lung cancer	0.000244	0.000371	CcSEcCtD
Baclofen—Hypotension—Docetaxel—lung cancer	0.000243	0.00037	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AVP—lung cancer	0.000243	0.000735	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADCY1—lung cancer	0.000243	0.000735	CbGpPWpGaD
Baclofen—Haematuria—Doxorubicin—lung cancer	0.000243	0.000369	CcSEcCtD
Baclofen—Abdominal pain—Paclitaxel—lung cancer	0.000243	0.000369	CcSEcCtD
Baclofen—Body temperature increased—Paclitaxel—lung cancer	0.000243	0.000369	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—lung cancer	0.000242	0.000733	CbGpPWpGaD
Baclofen—Hepatobiliary disease—Doxorubicin—lung cancer	0.000241	0.000366	CcSEcCtD
Baclofen—Angiopathy—Methotrexate—lung cancer	0.00024	0.000364	CcSEcCtD
Baclofen—Vomiting—Irinotecan—lung cancer	0.00024	0.000364	CcSEcCtD
Baclofen—Mediastinal disorder—Methotrexate—lung cancer	0.000238	0.000362	CcSEcCtD
Baclofen—Rash—Irinotecan—lung cancer	0.000238	0.000361	CcSEcCtD
Baclofen—Dermatitis—Irinotecan—lung cancer	0.000237	0.00036	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000237	0.00036	CcSEcCtD
Baclofen—Chills—Methotrexate—lung cancer	0.000237	0.00036	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SMARCA4—lung cancer	0.000237	0.000716	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PPP2R1B—lung cancer	0.000237	0.000716	CbGpPWpGaD
Baclofen—Headache—Irinotecan—lung cancer	0.000236	0.000358	CcSEcCtD
Baclofen—Insomnia—Docetaxel—lung cancer	0.000236	0.000358	CcSEcCtD
Baclofen—Diarrhoea—Cisplatin—lung cancer	0.000234	0.000355	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IGF1R—lung cancer	0.000234	0.000708	CbGpPWpGaD
Baclofen—Paraesthesia—Docetaxel—lung cancer	0.000234	0.000355	CcSEcCtD
Baclofen—Alopecia—Methotrexate—lung cancer	0.000234	0.000355	CcSEcCtD
Baclofen—Vomiting—Gemcitabine—lung cancer	0.000233	0.000354	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—lung cancer	0.000233	0.000704	CbGpPWpGaD
Baclofen—Bradycardia—Doxorubicin—lung cancer	0.000233	0.000354	CcSEcCtD
Baclofen—Dyspnoea—Docetaxel—lung cancer	0.000232	0.000353	CcSEcCtD
Baclofen—Somnolence—Docetaxel—lung cancer	0.000232	0.000352	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—lung cancer	0.000232	0.000351	CcSEcCtD
Baclofen—Rash—Gemcitabine—lung cancer	0.000231	0.000351	CcSEcCtD
Baclofen—Dermatitis—Gemcitabine—lung cancer	0.000231	0.000351	CcSEcCtD
Baclofen—Malnutrition—Methotrexate—lung cancer	0.00023	0.000349	CcSEcCtD
Baclofen—Headache—Gemcitabine—lung cancer	0.00023	0.000349	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HES1—lung cancer	0.00023	0.000695	CbGpPWpGaD
Baclofen—Rhinitis—Doxorubicin—lung cancer	0.000229	0.000348	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—lung cancer	0.000229	0.000348	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HSPB1—lung cancer	0.000229	0.000691	CbGpPWpGaD
Baclofen—Hypoaesthesia—Doxorubicin—lung cancer	0.000228	0.000346	CcSEcCtD
Baclofen—Decreased appetite—Docetaxel—lung cancer	0.000226	0.000344	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PTHLH—lung cancer	0.000226	0.000683	CbGpPWpGaD
Baclofen—Urinary tract disorder—Doxorubicin—lung cancer	0.000226	0.000343	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—RAF1—lung cancer	0.000226	0.000682	CbGpPWpGaD
Baclofen—Oedema peripheral—Doxorubicin—lung cancer	0.000225	0.000342	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—lung cancer	0.000225	0.000342	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—lung cancer	0.000225	0.000341	CcSEcCtD
Baclofen—Asthenia—Etoposide—lung cancer	0.000225	0.000341	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—lung cancer	0.000225	0.000341	CcSEcCtD
Baclofen—Fatigue—Docetaxel—lung cancer	0.000225	0.000341	CcSEcCtD
Baclofen—GABBR1—Neuronal System—HRAS—lung cancer	0.000225	0.000679	CbGpPWpGaD
Baclofen—Urethral disorder—Doxorubicin—lung cancer	0.000224	0.000341	CcSEcCtD
Baclofen—Nausea—Irinotecan—lung cancer	0.000224	0.00034	CcSEcCtD
Baclofen—Constipation—Docetaxel—lung cancer	0.000223	0.000338	CcSEcCtD
Baclofen—Pain—Docetaxel—lung cancer	0.000223	0.000338	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—IL2—lung cancer	0.000223	0.000673	CbGpPWpGaD
Baclofen—Back pain—Methotrexate—lung cancer	0.000223	0.000338	CcSEcCtD
Baclofen—Pruritus—Etoposide—lung cancer	0.000222	0.000337	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—lung cancer	0.000221	0.000335	CcSEcCtD
Baclofen—Asthenia—Paclitaxel—lung cancer	0.00022	0.000335	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—lung cancer	0.00022	0.000666	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	0.000219	0.000662	CbGpPWpGaD
Baclofen—Nausea—Gemcitabine—lung cancer	0.000218	0.000331	CcSEcCtD
Baclofen—Vomiting—Cisplatin—lung cancer	0.000218	0.00033	CcSEcCtD
Baclofen—Pruritus—Paclitaxel—lung cancer	0.000217	0.00033	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—lung cancer	0.000217	0.000329	CcSEcCtD
Baclofen—Rash—Cisplatin—lung cancer	0.000216	0.000328	CcSEcCtD
Baclofen—Dermatitis—Cisplatin—lung cancer	0.000216	0.000327	CcSEcCtD
Baclofen—Feeling abnormal—Docetaxel—lung cancer	0.000215	0.000326	CcSEcCtD
Baclofen—Diarrhoea—Etoposide—lung cancer	0.000214	0.000326	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—lung cancer	0.000214	0.000325	CcSEcCtD
Baclofen—Ill-defined disorder—Methotrexate—lung cancer	0.000213	0.000324	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—lung cancer	0.000213	0.000324	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—lung cancer	0.000213	0.000323	CcSEcCtD
Baclofen—Anaemia—Methotrexate—lung cancer	0.000213	0.000323	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ANXA1—lung cancer	0.000213	0.000643	CbGpPWpGaD
Baclofen—Cardiac disorder—Doxorubicin—lung cancer	0.000212	0.000322	CcSEcCtD
Baclofen—Flushing—Doxorubicin—lung cancer	0.000212	0.000322	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—lung cancer	0.000212	0.00064	CbGpPWpGaD
Baclofen—Diarrhoea—Paclitaxel—lung cancer	0.00021	0.000319	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ERBB3—lung cancer	0.00021	0.000635	CbGpPWpGaD
Baclofen—Angiopathy—Doxorubicin—lung cancer	0.000208	0.000315	CcSEcCtD
Baclofen—Malaise—Methotrexate—lung cancer	0.000207	0.000315	CcSEcCtD
Baclofen—Dizziness—Etoposide—lung cancer	0.000207	0.000315	CcSEcCtD
Baclofen—Vertigo—Methotrexate—lung cancer	0.000207	0.000314	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—lung cancer	0.000206	0.000313	CcSEcCtD
Baclofen—Body temperature increased—Docetaxel—lung cancer	0.000206	0.000313	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—lung cancer	0.000206	0.000313	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FLT1—lung cancer	0.000206	0.000622	CbGpPWpGaD
Baclofen—Chills—Doxorubicin—lung cancer	0.000205	0.000312	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—lung cancer	0.000204	0.00031	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—lung cancer	0.000204	0.000616	CbGpPWpGaD
Baclofen—Dizziness—Paclitaxel—lung cancer	0.000203	0.000309	CcSEcCtD
Baclofen—Nausea—Cisplatin—lung cancer	0.000203	0.000309	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—IL2—lung cancer	0.000202	0.000611	CbGpPWpGaD
Baclofen—Alopecia—Doxorubicin—lung cancer	0.000202	0.000307	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NOTCH3—lung cancer	0.000201	0.000609	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TERT—lung cancer	0.000201	0.000609	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APP—lung cancer	0.000201	0.000609	CbGpPWpGaD
Baclofen—Mental disorder—Doxorubicin—lung cancer	0.0002	0.000304	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGF9—lung cancer	0.0002	0.000604	CbGpPWpGaD
Baclofen—Convulsion—Methotrexate—lung cancer	0.000199	0.000303	CcSEcCtD
Baclofen—Vomiting—Etoposide—lung cancer	0.000199	0.000303	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—lung cancer	0.000199	0.000302	CcSEcCtD
Baclofen—Rash—Etoposide—lung cancer	0.000198	0.0003	CcSEcCtD
Baclofen—Dermatitis—Etoposide—lung cancer	0.000197	0.0003	CcSEcCtD
Baclofen—Headache—Etoposide—lung cancer	0.000196	0.000298	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—lung cancer	0.000196	0.000298	CcSEcCtD
Baclofen—Chest pain—Methotrexate—lung cancer	0.000196	0.000297	CcSEcCtD
Baclofen—Myalgia—Methotrexate—lung cancer	0.000196	0.000297	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FGFR1—lung cancer	0.000196	0.000591	CbGpPWpGaD
Baclofen—Vomiting—Paclitaxel—lung cancer	0.000195	0.000297	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—lung cancer	0.000195	0.000296	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000194	0.000295	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—POMC—lung cancer	0.000194	0.000587	CbGpPWpGaD
Baclofen—Rash—Paclitaxel—lung cancer	0.000194	0.000294	CcSEcCtD
Baclofen—Dermatitis—Paclitaxel—lung cancer	0.000194	0.000294	CcSEcCtD
Baclofen—Discomfort—Methotrexate—lung cancer	0.000193	0.000294	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HIF1A—lung cancer	0.000193	0.000582	CbGpPWpGaD
Baclofen—Back pain—Doxorubicin—lung cancer	0.000193	0.000293	CcSEcCtD
Baclofen—Headache—Paclitaxel—lung cancer	0.000193	0.000292	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—JUNB—lung cancer	0.000191	0.000577	CbGpPWpGaD
Baclofen—Confusional state—Methotrexate—lung cancer	0.000189	0.000287	CcSEcCtD
Baclofen—Vision blurred—Doxorubicin—lung cancer	0.000188	0.000285	CcSEcCtD
Baclofen—Asthenia—Docetaxel—lung cancer	0.000187	0.000284	CcSEcCtD
Baclofen—Infection—Methotrexate—lung cancer	0.000187	0.000283	CcSEcCtD
Baclofen—Nausea—Etoposide—lung cancer	0.000186	0.000283	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—APOA1—lung cancer	0.000186	0.000562	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—lung cancer	0.000185	0.00056	CbGpPWpGaD
Baclofen—Ill-defined disorder—Doxorubicin—lung cancer	0.000185	0.000281	CcSEcCtD
Baclofen—Pruritus—Docetaxel—lung cancer	0.000184	0.00028	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—KDR—lung cancer	0.000184	0.000557	CbGpPWpGaD
Baclofen—Nervous system disorder—Methotrexate—lung cancer	0.000184	0.00028	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—lung cancer	0.000184	0.00028	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	0.000184	0.000555	CbGpPWpGaD
Baclofen—Agitation—Doxorubicin—lung cancer	0.000183	0.000278	CcSEcCtD
Baclofen—Nausea—Paclitaxel—lung cancer	0.000183	0.000277	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—lung cancer	0.000182	0.000277	CcSEcCtD
Baclofen—Hyperhidrosis—Methotrexate—lung cancer	0.000181	0.000276	CcSEcCtD
Baclofen—Malaise—Doxorubicin—lung cancer	0.00018	0.000273	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—lung cancer	0.000179	0.000542	CbGpPWpGaD
Baclofen—Vertigo—Doxorubicin—lung cancer	0.000179	0.000272	CcSEcCtD
Baclofen—Anorexia—Methotrexate—lung cancer	0.000179	0.000272	CcSEcCtD
Baclofen—Syncope—Doxorubicin—lung cancer	0.000179	0.000271	CcSEcCtD
Baclofen—Diarrhoea—Docetaxel—lung cancer	0.000178	0.000271	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000178	0.000538	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—POMC—lung cancer	0.000176	0.000533	CbGpPWpGaD
Baclofen—Palpitations—Doxorubicin—lung cancer	0.000176	0.000267	CcSEcCtD
Baclofen—Hypotension—Methotrexate—lung cancer	0.000175	0.000266	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—lung cancer	0.000175	0.000266	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—STK11—lung cancer	0.000173	0.000524	CbGpPWpGaD
Baclofen—Convulsion—Doxorubicin—lung cancer	0.000173	0.000262	CcSEcCtD
Baclofen—Dizziness—Docetaxel—lung cancer	0.000172	0.000262	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—lung cancer	0.000172	0.000261	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—IL6R—lung cancer	0.000172	0.00052	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000171	0.00026	CcSEcCtD
Baclofen—Insomnia—Methotrexate—lung cancer	0.00017	0.000258	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—KIT—lung cancer	0.00017	0.000513	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—lung cancer	0.00017	0.000513	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—lung cancer	0.00017	0.000513	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—NRAS—lung cancer	0.00017	0.000513	CbGpPWpGaD
Baclofen—Chest pain—Doxorubicin—lung cancer	0.00017	0.000257	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—lung cancer	0.00017	0.000257	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—lung cancer	0.000169	0.000257	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—lung cancer	0.000169	0.000256	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000168	0.000256	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EGF—lung cancer	0.000168	0.000507	CbGpPWpGaD
Baclofen—Discomfort—Doxorubicin—lung cancer	0.000168	0.000254	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—lung cancer	0.000167	0.000254	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FOXO3—lung cancer	0.000167	0.000505	CbGpPWpGaD
Baclofen—Somnolence—Methotrexate—lung cancer	0.000167	0.000253	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—lung cancer	0.000166	0.000252	CcSEcCtD
Baclofen—Vomiting—Docetaxel—lung cancer	0.000166	0.000251	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—lung cancer	0.000165	0.000251	CcSEcCtD
Baclofen—Rash—Docetaxel—lung cancer	0.000164	0.000249	CcSEcCtD
Baclofen—Dermatitis—Docetaxel—lung cancer	0.000164	0.000249	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—lung cancer	0.000164	0.000249	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—MAP2K1—lung cancer	0.000164	0.000495	CbGpPWpGaD
Baclofen—Decreased appetite—Methotrexate—lung cancer	0.000163	0.000248	CcSEcCtD
Baclofen—Headache—Docetaxel—lung cancer	0.000163	0.000248	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—lung cancer	0.000163	0.000492	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—lung cancer	0.000163	0.000491	CbGpPWpGaD
Baclofen—Oedema—Doxorubicin—lung cancer	0.000163	0.000247	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—lung cancer	0.000162	0.000246	CcSEcCtD
Baclofen—Fatigue—Methotrexate—lung cancer	0.000162	0.000246	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—POMC—lung cancer	0.000162	0.000488	CbGpPWpGaD
Baclofen—Infection—Doxorubicin—lung cancer	0.000162	0.000245	CcSEcCtD
Baclofen—Pain—Methotrexate—lung cancer	0.000161	0.000244	CcSEcCtD
Baclofen—Shock—Doxorubicin—lung cancer	0.00016	0.000243	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—BRAF—lung cancer	0.00016	0.000482	CbGpPWpGaD
Baclofen—Nervous system disorder—Doxorubicin—lung cancer	0.000159	0.000242	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—lung cancer	0.000159	0.000241	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—lung cancer	0.000158	0.00024	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IL6R—lung cancer	0.000158	0.000477	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CREBBP—lung cancer	0.000157	0.000476	CbGpPWpGaD
Baclofen—Hyperhidrosis—Doxorubicin—lung cancer	0.000157	0.000239	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—AVP—lung cancer	0.000157	0.000474	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—lung cancer	0.000156	0.000472	CbGpPWpGaD
Baclofen—Anorexia—Doxorubicin—lung cancer	0.000155	0.000235	CcSEcCtD
Baclofen—Nausea—Docetaxel—lung cancer	0.000155	0.000235	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—lung cancer	0.000155	0.000235	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—EGFR—lung cancer	0.000155	0.000468	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Methotrexate—lung cancer	0.000154	0.000233	CcSEcCtD
Baclofen—Hypotension—Doxorubicin—lung cancer	0.000152	0.000231	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IGF1R—lung cancer	0.000151	0.000456	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAP2K1—lung cancer	0.00015	0.000454	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—lung cancer	0.00015	0.000454	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—lung cancer	0.000149	0.000451	CbGpPWpGaD
Baclofen—Urticaria—Methotrexate—lung cancer	0.000149	0.000226	CcSEcCtD
Baclofen—Body temperature increased—Methotrexate—lung cancer	0.000148	0.000225	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—lung cancer	0.000148	0.000225	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HES1—lung cancer	0.000148	0.000448	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000148	0.000225	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—lung cancer	0.000148	0.000447	CbGpPWpGaD
Baclofen—Insomnia—Doxorubicin—lung cancer	0.000147	0.000223	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—KRAS—lung cancer	0.000146	0.000442	CbGpPWpGaD
Baclofen—Paraesthesia—Doxorubicin—lung cancer	0.000146	0.000222	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—RAF1—lung cancer	0.000145	0.000439	CbGpPWpGaD
Baclofen—Dyspnoea—Doxorubicin—lung cancer	0.000145	0.00022	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—lung cancer	0.000145	0.000219	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—IL2—lung cancer	0.000143	0.000434	CbGpPWpGaD
Baclofen—Dyspepsia—Doxorubicin—lung cancer	0.000143	0.000217	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—lung cancer	0.000142	0.000429	CbGpPWpGaD
Baclofen—Decreased appetite—Doxorubicin—lung cancer	0.000141	0.000215	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	0.00014	0.000425	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00014	0.000213	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—lung cancer	0.00014	0.000213	CcSEcCtD
Baclofen—Constipation—Doxorubicin—lung cancer	0.000139	0.000211	CcSEcCtD
Baclofen—Pain—Doxorubicin—lung cancer	0.000139	0.000211	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—lung cancer	0.000136	0.000412	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB3—lung cancer	0.000135	0.00041	CbGpPWpGaD
Baclofen—Asthenia—Methotrexate—lung cancer	0.000135	0.000205	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—lung cancer	0.000134	0.000406	CbGpPWpGaD
Baclofen—Feeling abnormal—Doxorubicin—lung cancer	0.000134	0.000203	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MDM2—lung cancer	0.000134	0.000404	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAF1—lung cancer	0.000133	0.000403	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Doxorubicin—lung cancer	0.000133	0.000202	CcSEcCtD
Baclofen—Pruritus—Methotrexate—lung cancer	0.000133	0.000202	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ERBB2—lung cancer	0.000132	0.000398	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—lung cancer	0.00013	0.000394	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MTOR—lung cancer	0.00013	0.000393	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—lung cancer	0.00013	0.000393	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TERT—lung cancer	0.00013	0.000392	CbGpPWpGaD
Baclofen—Urticaria—Doxorubicin—lung cancer	0.000129	0.000196	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—lung cancer	0.000129	0.000195	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—lung cancer	0.000129	0.000195	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—lung cancer	0.000128	0.000195	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGFR1—lung cancer	0.000126	0.000381	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—lung cancer	0.000125	0.000378	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HRAS—lung cancer	0.000124	0.000375	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIF1A—lung cancer	0.000124	0.000375	CbGpPWpGaD
Baclofen—Dizziness—Methotrexate—lung cancer	0.000124	0.000188	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—lung cancer	0.000121	0.000365	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOA1—lung cancer	0.00012	0.000362	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—lung cancer	0.00012	0.000362	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—lung cancer	0.000119	0.000361	CbGpPWpGaD
Baclofen—Vomiting—Methotrexate—lung cancer	0.000119	0.000181	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000119	0.000359	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—lung cancer	0.000119	0.000359	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—lung cancer	0.000119	0.000359	CbGpPWpGaD
Baclofen—Rash—Methotrexate—lung cancer	0.000118	0.00018	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—lung cancer	0.000118	0.00018	CcSEcCtD
Baclofen—Headache—Methotrexate—lung cancer	0.000118	0.000179	CcSEcCtD
Baclofen—Asthenia—Doxorubicin—lung cancer	0.000117	0.000177	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCND1—lung cancer	0.000116	0.000352	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUN—lung cancer	0.000116	0.000351	CbGpPWpGaD
Baclofen—Pruritus—Doxorubicin—lung cancer	0.000115	0.000175	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MMP9—lung cancer	0.000113	0.000342	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1A—lung cancer	0.000113	0.000341	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTEN—lung cancer	0.000112	0.00034	CbGpPWpGaD
Baclofen—Nausea—Methotrexate—lung cancer	0.000112	0.000169	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	0.000111	0.000336	CbGpPWpGaD
Baclofen—Diarrhoea—Doxorubicin—lung cancer	0.000111	0.000169	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AKT1—lung cancer	0.00011	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KIT—lung cancer	0.000109	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—lung cancer	0.000109	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—lung cancer	0.000109	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—NRAS—lung cancer	0.000109	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGF—lung cancer	0.000108	0.000327	CbGpPWpGaD
Baclofen—Dizziness—Doxorubicin—lung cancer	0.000107	0.000163	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EP300—lung cancer	0.000107	0.000324	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—lung cancer	0.000105	0.000317	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SRC—lung cancer	0.000104	0.000315	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—POMC—lung cancer	0.000104	0.000315	CbGpPWpGaD
Baclofen—Vomiting—Doxorubicin—lung cancer	0.000103	0.000157	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—BRAF—lung cancer	0.000103	0.000311	CbGpPWpGaD
Baclofen—Rash—Doxorubicin—lung cancer	0.000102	0.000156	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—lung cancer	0.000102	0.000155	CcSEcCtD
Baclofen—Headache—Doxorubicin—lung cancer	0.000102	0.000155	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IL6R—lung cancer	0.000102	0.000307	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—lung cancer	0.000102	0.000307	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CREBBP—lung cancer	0.000101	0.000307	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	0.000101	0.000304	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—lung cancer	0.000101	0.000304	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NRAS—lung cancer	0.0001	0.000303	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—lung cancer	9.97e-05	0.000301	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAP2K1—lung cancer	9.68e-05	0.000293	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—lung cancer	9.66e-05	0.000147	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—lung cancer	9.62e-05	0.000291	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—lung cancer	9.6e-05	0.00029	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—lung cancer	9.52e-05	0.000288	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—lung cancer	9.41e-05	0.000285	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—lung cancer	9.34e-05	0.000282	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—lung cancer	9.14e-05	0.000276	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—lung cancer	8.65e-05	0.000261	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—lung cancer	8.63e-05	0.000261	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MDM2—lung cancer	8.61e-05	0.00026	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAF1—lung cancer	8.58e-05	0.00026	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—lung cancer	8.49e-05	0.000257	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MTOR—lung cancer	8.38e-05	0.000253	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—lung cancer	8.38e-05	0.000253	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—lung cancer	8.05e-05	0.000243	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRAS—lung cancer	8e-05	0.000242	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—lung cancer	7.93e-05	0.00024	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—lung cancer	7.78e-05	0.000235	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—lung cancer	7.71e-05	0.000233	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—lung cancer	7.7e-05	0.000233	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—lung cancer	7.67e-05	0.000232	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—lung cancer	7.66e-05	0.000232	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—lung cancer	7.5e-05	0.000227	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUN—lung cancer	7.49e-05	0.000226	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HRAS—lung cancer	7.34e-05	0.000222	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—lung cancer	7.29e-05	0.00022	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1A—lung cancer	7.26e-05	0.000219	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—lung cancer	7.24e-05	0.000219	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—lung cancer	7.07e-05	0.000214	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—lung cancer	7.02e-05	0.000212	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EP300—lung cancer	6.91e-05	0.000209	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SRC—lung cancer	6.72e-05	0.000203	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—lung cancer	6.54e-05	0.000198	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—lung cancer	6.48e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—lung cancer	6.48e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NRAS—lung cancer	6.46e-05	0.000195	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK3—lung cancer	6.19e-05	0.000187	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—lung cancer	6.02e-05	0.000182	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—lung cancer	5.89e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—lung cancer	5.56e-05	0.000168	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—lung cancer	5.11e-05	0.000154	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—lung cancer	4.94e-05	0.000149	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRAS—lung cancer	4.73e-05	0.000143	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—lung cancer	4.52e-05	0.000137	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—lung cancer	4.17e-05	0.000126	CbGpPWpGaD
